Evaluation of optimal regimens for treatment of rifampicin resistant-tuberculosis: Multicenter, randomized controlled study in China

被引：0
作者：
Tang, Shenjie [1 ]
Yao, Lan [1 ]
Hao, Xiaohui [1 ]
Liu, Yidian [1 ]
机构：
[1] Capital Med Univ, Beijing Chest Hosp, TB Multidisciplinary Diag & Treatment Ctr, Beijing, Peoples R China
来源：
EUROPEAN RESPIRATORY JOURNAL | 2015年 / 46卷
关键词：
Tuberculosis; -; management; Treatments; MDR-TB;
D O I：
10.1183/13993003.congress-2015.PA3341
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA3341
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Adverse Events Associated with Treatment of Multidrug-Resistant Tuberculosis in China: An Ambispective Cohort Study
    Zhang, Yang
    Wu, Shanshan
    Xia, Yinyin
    Wang, Ni
    Zhou, Lin
    Wang, Jing
    Fang, Renfei
    Sun, Feng
    Chen, Mingting
    Zhan, Siyan
    MEDICAL SCIENCE MONITOR, 2017, 23 : 2348 - 2356
  • [22] Evaluating newly approved drugs in combination regimens for multidrug-resistant tuberculosis with fluoroquinolone resistance (endTB-Q): study protocol for a multi-country randomized controlled trial
    S. B. Patil
    M. Tamirat
    K. Khazhidinov
    E. Ardizzoni
    M. Atger
    A. Austin
    E. Baudin
    M. Bekhit
    S. Bektasov
    E. Berikova
    M. Bonnet
    R. Caboclo
    M. Chaudhry
    V. Chavan
    S. Cloez
    J. Coit
    S. Coutisson
    Z. Dakenova
    B. C. De Jong
    C. Delifer
    S. Demaisons
    J. M. Do
    D. Dos Santos Tozzi
    V. Ducher
    G. Ferlazzo
    M. Gouillou
    U. Khan
    M. Kunda
    N. Lachenal
    A. N. LaHood
    L. Lecca
    M. Mazmanian
    H. McIlleron
    M. Moreau
    M. Moschioni
    P. Nahid
    E. Osso
    L. Oyewusi
    S. Panda
    A. Pâquet
    P. Thuong Huu
    L. Pichon
    M. L. Rich
    P. Rupasinghe
    N. Salahuddin
    E. Sanchez Garavito
    K. J. Seung
    G. E. Velásquez
    M. Vallet
    F. Varaine
    Trials, 24
  • [23] Evaluating newly approved drugs in combination regimens for multidrug-resistant tuberculosis with fluoroquinolone resistance (endTB-Q): study protocol for a multi-country randomized controlled trial
    Patil, S. B.
    Tamirat, M.
    Khazhidinov, K.
    Ardizzoni, E.
    Atger, M.
    Austin, A.
    Baudin, E.
    Bekhit, M.
    Bektasov, S.
    Berikova, E.
    Bonnet, M.
    Caboclo, R.
    Chaudhry, M.
    Chavan, V.
    Cloez, S.
    Coit, J.
    Coutisson, S.
    Dakenova, Z.
    De Jong, B. C.
    Delifer, C.
    Demaisons, S.
    Do, J. M.
    Dos Santos Tozzi, D.
    Ducher, V.
    Ferlazzo, G.
    Gouillou, M.
    Khan, U.
    Kunda, M.
    Lachenal, N.
    LaHood, A. N.
    Lecca, L.
    Mazmanian, M.
    McIlleron, H.
    Moreau, M.
    Moschioni, M.
    Nahid, P.
    Osso, E.
    Oyewusi, L.
    Panda, S.
    Paquet, A.
    Thuong Huu, P.
    Pichon, L.
    Rich, M. L.
    Rupasinghe, P.
    Salahuddin, N.
    Sanchez Garavito, E.
    Seung, K. J.
    Velasquez, G. E.
    Vallet, M.
    Varaine, F.
    TRIALS, 2023, 24 (01)
  • [24] Efficacy and safety of the all-oral bedaquiline-containing regimen as treatment for pediatric multidrug/rifampicin-resistant tuberculosis: a multicenter, retrospective, cohort study
    Sun, Wen-Wen
    Yang, Ming
    Chen, Xiao-Hong
    Fan, Li-Chao
    Wu, Hao-Yu
    Zhang, Shao-Jun
    Chen, Yu
    Fan, Lin
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2024, 22 (04) : 219 - 227
  • [25] An All-Oral 6-Month Regimen for Multidrug-Resistant Tuberculosis A Multicenter, Randomized Controlled Clinical Trial (the NExT Study)
    Esmail, Aliasgar
    Oelofse, Suzette
    Lombard, Carl
    Perumal, Rubeshan
    Mbuthini, Linda
    Mahomed, Akhter Goolam
    Variava, Ebrahim
    Black, John
    Oluboyo, Patrick
    Gwentshu, Nelile
    Ngam, Eric
    Ackerman, Tertius
    Marais, Linde
    Mottay, Lynelle
    Meier, Stuart
    Pooran, Anil
    Tomasicchio, Michele
    Te Riele, Julian
    Derendinger, Brigitta
    Ndjeka, Norbert
    Maartens, Gary
    Warren, Robin
    Martinson, Neil
    Dheda, Keertan
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205 (10) : 1214 - 1227
  • [26] Rifampicin Resistance and Multidrug-Resistant Tuberculosis Detection Using Xpert MTB/RIF in Wuhan, China: A Retrospective Study
    Huang, Hai
    Zhang, Yanlin
    Li, Sheng
    Wang, Jun
    Chen, Jun
    Pan, Zhiyun
    Gan, Hui
    MICROBIAL DRUG RESISTANCE, 2018, 24 (05) : 675 - 679
  • [27] Towards tailored regimens in the treatment of drug-resistant tuberculosis: a retrospective study in two Italian reference Centres
    Riccardi, Niccolo
    Alagna, Riccardo
    Saderi, Laura
    Ferrarese, Maurizio
    Castellotti, Paola
    Mazzola, Ester
    De Lorenzo, Saverio
    Viggiani, Pietro
    Udwadia, Zarir
    Besozzi, Giorgio
    Cirillo, Daniela
    Sotgiu, Giovanni
    Codecasa, Luigi
    BMC INFECTIOUS DISEASES, 2019, 19 (1)
  • [28] Towards tailored regimens in the treatment of drug-resistant tuberculosis: a retrospective study in two Italian reference Centres
    Niccolò Riccardi
    Riccardo Alagna
    Laura Saderi
    Maurizio Ferrarese
    Paola Castellotti
    Ester Mazzola
    Saverio De Lorenzo
    Pietro Viggiani
    Zarir Udwadia
    Giorgio Besozzi
    Daniela Cirillo
    Giovanni Sotgiu
    Luigi Codecasa
    BMC Infectious Diseases, 19
  • [29] Efficacy of Electroacupuncture for the Treatment of Postherpetic Neuralgia: Study Protocol for a Multicenter Randomized Controlled Trial
    Sun, Ruohan
    Li, Shimin
    Ren, Leilei
    Xia, Yunfan
    Wang, Yiyi
    Bian, Zhiyuan
    Fang, Jianqiao
    Zhang, Zuyong
    JOURNAL OF PAIN RESEARCH, 2022, 15 : 959 - 968
  • [30] Bedaquiline versus injectable containing regimens for rifampicin-resistant and multidrug-resistant tuberculosis in a reference center in Brazil - a real-world evidence study using a retrospective design
    Santos, Ana Paula
    Benace Jr, Cristovao Jorge
    Leung, Janaina Aparecida de Medeiros
    Kritski, Afranio Lineu
    Mello, Fernanda Carvalho de Queiroz
    BMC INFECTIOUS DISEASES, 2024, 24 (01)
12345